tiprankstipranks
Trending News
More News >
FibroBiologics, Inc. (FBLG)
NASDAQ:FBLG
US Market

FibroBiologics, Inc. (FBLG) Financial Statements

Compare
226 Followers

FibroBiologics, Inc. Financial Overview

FibroBiologics, Inc.'s market cap is currently $22.88M. The company's EPS TTM is $-0.13; its P/E ratio is -0.69; FibroBiologics, Inc. is scheduled to report earnings on October 31, 2025, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -13.74M$ -8.89M$ -4.47M$ -1.58M$ -1.17M
EBITDA$ -10.57M$ -15.90M$ -4.37M$ -1.58M$ 0.00
Net Income$ -11.16M$ -16.48M$ -5.12M$ -1.58M$ -1.17M
Balance Sheet
Cash & Short-Term Investments$ 13.98M$ 9.16M$ 2.27M$ 407.00K$ 0.00
Total Assets$ 16.45M$ 11.82M$ 4.82M$ 468.00K$ 0.00
Total Debt$ 10.55M$ 1.75M$ 7.52M$ 1.30M$ 0.00
Net Debt$ -3.43M$ -7.42M$ 5.26M$ 893.00K$ 0.00
Total Liabilities$ 13.71M$ 10.57M$ 8.82M$ 1.76M$ 0.00
Stockholders' Equity$ 2.73M$ 1.25M$ -4.00M$ -1.29M$ 0.00
Cash Flow
Free Cash Flow$ -12.09M$ -6.90M$ -4.07M$ -1.41M$ -1.17M
Operating Cash Flow$ -11.90M$ -6.40M$ -4.07M$ -1.41M$ -1.17M
Investing Cash Flow$ -184.00K$ -495.00K$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 16.91M$ 13.79M$ 5.92M$ 1.82M$ 1.17M
Currency in USD

FibroBiologics, Inc. Earnings and Revenue History

FibroBiologics, Inc. Debt to Assets

FibroBiologics, Inc. Cash Flow

FibroBiologics, Inc. Forecast EPS vs Actual EPS